OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 151 filers reported holding OCULAR THERAPEUTIX INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,000 | -41.1% | 20,138 | -2.9% | 0.00% | – |
| Q2 2023 | $107,000 | -4.5% | 20,738 | -1.6% | 0.00% | – |
| Q1 2023 | $112,000 | +89.8% | 21,068 | 0.0% | 0.00% | – |
| Q4 2022 | $59,000 | -34.4% | 21,068 | -3.2% | 0.00% | – |
| Q3 2022 | $90,000 | +3.4% | 21,768 | 0.0% | 0.00% | – |
| Q2 2022 | $87,000 | -19.4% | 21,768 | 0.0% | 0.00% | – |
| Q1 2022 | $108,000 | -19.4% | 21,768 | +13.0% | 0.00% | – |
| Q4 2021 | $134,000 | +4.7% | 19,268 | +50.9% | 0.00% | – |
| Q3 2021 | $128,000 | -12.3% | 12,768 | +24.3% | 0.00% | – |
| Q2 2021 | $146,000 | -21.1% | 10,268 | -9.0% | 0.00% | -100.0% |
| Q1 2021 | $185,000 | -29.1% | 11,284 | -10.9% | 0.00% | 0.0% |
| Q4 2020 | $261,000 | -67.0% | 12,660 | -86.8% | 0.00% | -75.0% |
| Q2 2020 | $790,000 | – | 95,639 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,932,607 | $40,643,000 | 15.56% |
| Lamond Capital Partners LLC | 711,533 | $14,964,000 | 15.19% |
| Polaris Venture Management Co. V, L.L.C. | 1,230,009 | $25,867,000 | 11.54% |
| NOTTINGHAM ADVISORS, INC. | 171,985 | $3,617,000 | 0.60% |
| Portolan Capital Management | 122,518 | $2,577,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,365,000 | 0.33% |
| Rotella Capital Management, Inc. | 18,461 | $388,000 | 0.32% |
| Monashee Investment Management LLC | 28,834 | $606,000 | 0.29% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 335,498 | $7,056,000 | 0.24% |
| BAILARD, INC. | 55,000 | $1,157,000 | 0.18% |